A detailed history of Manufacturers Life Insurance Company, The transactions in Veracyte, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 41,917 shares of VCYT stock, worth $1.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,917
Previous 42,766 1.99%
Holding current value
$1.71 Million
Previous $926,000 54.0%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$21.0 - $35.25 $17,829 - $29,927
-849 Reduced 1.99%
41,917 $1.43 Million
Q2 2024

Aug 14, 2024

BUY
$18.86 - $23.55 $40,266 - $50,279
2,135 Added 5.25%
42,766 $926,000
Q1 2024

May 14, 2024

BUY
$21.0 - $29.1 $101,934 - $141,251
4,854 Added 13.57%
40,631 $900,000
Q4 2023

Feb 13, 2024

SELL
$19.72 - $28.68 $12,305 - $17,896
-624 Reduced 1.71%
35,777 $984,000
Q3 2023

Nov 15, 2023

BUY
$22.33 - $29.92 $159,771 - $214,077
7,155 Added 24.46%
36,401 $812,000
Q2 2023

Aug 11, 2023

BUY
$20.96 - $26.99 $14,273 - $18,380
681 Added 2.38%
29,246 $744,000
Q1 2023

May 15, 2023

BUY
$20.58 - $27.89 $2,449 - $3,318
119 Added 0.42%
28,684 $639,000
Q4 2022

Aug 11, 2023

BUY
$15.31 - $29.94 $3,582 - $7,005
234 Added 0.83%
28,565 $677,000
Q4 2022

Feb 13, 2023

BUY
$15.31 - $29.94 $3,582 - $7,005
234 Added 0.83%
28,565 $677,000
Q3 2022

Aug 11, 2023

SELL
$16.58 - $27.9 $9,218 - $15,512
-556 Reduced 1.92%
28,331 $470,000
Q3 2022

Nov 03, 2022

SELL
$16.58 - $27.9 $9,218 - $15,512
-556 Reduced 1.92%
28,331 $470,000
Q2 2022

Aug 11, 2023

BUY
$15.45 - $29.52 $17,257 - $32,973
1,117 Added 4.02%
28,887 $574,000
Q2 2022

Aug 15, 2022

BUY
$15.45 - $29.52 $17,257 - $32,973
1,117 Added 4.02%
28,887 $575,000
Q1 2022

Aug 11, 2023

SELL
$21.94 - $42.51 $20,053 - $38,854
-914 Reduced 3.19%
27,770 $765,000
Q1 2022

May 20, 2022

SELL
$21.94 - $42.51 $141,008 - $273,211
-6,427 Reduced 18.79%
27,770 $766,000
Q4 2021

Feb 16, 2022

SELL
$36.09 - $53.79 $5,413 - $8,068
-150 Reduced 0.44%
34,197 $1.41 Million
Q3 2021

Nov 12, 2021

SELL
$35.62 - $52.97 $122,746 - $182,534
-3,446 Reduced 9.12%
34,347 $1.6 Million
Q2 2021

Aug 12, 2021

BUY
$32.94 - $56.62 $27,669 - $47,560
840 Added 2.27%
37,793 $1.51 Million
Q1 2021

May 03, 2021

BUY
$44.47 - $81.38 $125,538 - $229,735
2,823 Added 8.27%
36,953 $1.99 Million
Q4 2020

Feb 12, 2021

BUY
$32.49 - $61.88 $60,203 - $114,663
1,853 Added 5.74%
34,130 $1.67 Million
Q3 2020

Nov 09, 2020

BUY
$26.73 - $35.67 $62,895 - $83,931
2,353 Added 7.86%
32,277 $1.05 Million
Q2 2020

Aug 10, 2020

SELL
$19.49 - $28.11 $4,950 - $7,139
-254 Reduced 0.84%
29,924 $732,000
Q1 2020

May 15, 2020

BUY
$16.13 - $30.17 $31,485 - $58,891
1,952 Added 6.92%
30,178 $734,000
Q4 2019

Feb 14, 2020

SELL
$20.78 - $29.99 $15,314 - $22,102
-737 Reduced 2.54%
28,226 $788,000
Q3 2019

Nov 12, 2019

BUY
$23.87 - $30.93 $5,752 - $7,454
241 Added 0.84%
28,963 $702,000
Q2 2019

Aug 14, 2019

BUY
$22.1 - $28.56 $219,165 - $283,229
9,917 Added 52.74%
28,722 $819,000
Q1 2019

May 13, 2019

BUY
$12.0 - $25.76 $225,660 - $484,416
18,805 New
18,805 $470,000
Q4 2018

Feb 14, 2019

SELL
$9.15 - $14.85 $105,243 - $170,804
-11,502 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$9.55 - $12.64 $105,288 - $139,356
-11,025 Reduced 48.94%
11,502 $110,000
Q2 2018

Aug 14, 2018

BUY
$5.39 - $9.66 $1,018 - $1,825
189 Added 0.85%
22,527 $211,000
Q1 2018

May 15, 2018

BUY
$5.44 - $6.97 $805 - $1,031
148 Added 0.67%
22,338 $125,000
Q4 2017

Feb 08, 2018

BUY
$6.05 - $9.37 $1,766 - $2,736
292 Added 1.33%
22,190 $145,000
Q3 2017

Nov 14, 2017

BUY
$7.81 - $8.77 $171,023 - $192,045
21,898
21,898 $192,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.93B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.